Abstract

Single-particle cryo-electron microscopy (cryo-EM) and three-dimensional (3D) image processing have gained importance in the last few years to obtain atomic structures of drug targets. Obtaining atomic-resolution 3D structure better than ~2.5 Å is a standard approach in pharma companies to design and optimize therapeutic compounds against drug targets like proteins. Protein crystallography is the main technique in solving the structures of drug targets at atomic resolution. However, this technique requires protein crystals which in turn is a major bottleneck. It was not possible to obtain the structure of proteins better than 2.5 Å resolution by any other methods apart from protein crystallography until 2015. Recent advances in single-particle cryo-EM and 3D image processing have led to a resolution revolution in the field of structural biology that has led to high-resolution protein structures, thus breaking the cryo-EM resolution barriers to facilitate drug discovery. There are 24 structures solved by single-particle cryo-EM with resolution 2.5 Å or better in the EMDataBank (EMDB) till date. Among these, five cryo-EM 3D reconstructions of proteins in the EMDB have their associated coordinates deposited in Protein Data Bank (PDB), with bound inhibitor/ ligand. Thus, for the first time, single-particle cryo-EM was included in the structure-based drug design (SBDD) pipeline for solving protein structures independently or where crystallography has failed to crystallize the protein. Further, this technique can be complementary and supplementary to protein crystallography field in solving 3D structures. Thus, single-particle cryo-EM can become a standard approach in pharmaceutical industry in the design, validation, and optimization of therapeutic compounds targeting therapeutically important protein molecules during preclinical drug discovery research. The present chapter will describe briefly the history and the principles of single-particle cryo-EM and 3D image processing to obtain atomic-resolution structure of proteins and their complex with their drug targets/ligands.

Highlights

  • The importance of structural biology in understanding the principles of molecular function of proteins, the workforce of cellular world, underpins its use in health science and pharma industries

  • Protein crystallography was ruling the world of structure-based drug design (SBDD)

  • The remaining 2% of structures by large were solved by electron microscopy, electron crystallography, hybrid, and other methods, which include neutron diffraction, solution scattering, fiber diffraction

Read more

Summary

Introduction

The importance of structural biology in understanding the principles of molecular function of proteins, the workforce of cellular world, underpins its use in health science and pharma industries. Before that the first EM structure came from Henderson and Unwin [13] of purple membrane protein by electron crystallography, but not using cryo, and the resolution was bit low at 7 Å. This encouraged Joachim Frank to develop image processing algorithms for solving protein structures by building 3D reconstruction from fussy cryo-EM projection images of proteins [14–16]. Other developments like field emission gun electron source, direct electron detectors, and movie-based cryo-EM imaging methods have led to an avalanche of high-resolution single-particle cryo-EM protein structures [5, 6, 18].

The Single-Particle Cryo-EM at High Resolution
Specimen Preparation for Single-Particle Cryo-EM
Data Collection
Image Processing and Three-Dimensional Reconstruction
Resolution
Model Building
Validation
Heterogeneity
Single-Particle Cryo-EM Applications in SBDD
Findings
Conclusions and Future Prospective
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call